Literature DB >> 12297274

Human RhoGAP domain-containing proteins: structure, function and evolutionary relationships.

Jeremy Peck1, Gilbert Douglas, Catherine H Wu, Peter D Burbelo.   

Abstract

Proteins containing a RhoGAP (Rho GTPase activating protein) domain usually function to catalyze the hydrolysis of GTP that is bound to Rho, Rac and/or Cdc42, inactivating these regulators of the actin cytoskeleton. Using database searches, at least 53 distinct RhoGAP domain-containing proteins are likely to be encoded in human DNA. Phylogenetic analysis of only the RhoGAP domains divides these proteins into distinct families that appear to be functionally related. We also review the current understanding of the structure and likely functions of these human proteins. The presence of RhoGAP domains in a number of different human proteins suggests that cytoskeletal changes, regulated by Rho GTPase, may be integrated with many different signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297274     DOI: 10.1016/s0014-5793(02)03331-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  53 in total

1.  A novel testicular RhoGAP-domain protein induces apoptosis.

Authors:  M Hossein Modarressi; Min Cheng; Heide A Tarnasky; Nathalie Lamarche-Vane; Dirk G de Rooij; Yibing Ruan; Frans A van der Hoorn
Journal:  Biol Reprod       Date:  2004-08-11       Impact factor: 4.285

2.  Rho/RacGAPs: embarras de richesse?

Authors:  Roland Csépányi-Kömi; Magdolna Lévay; Erzsébet Ligeti
Journal:  Small GTPases       Date:  2012-07-01

Review 3.  GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo.

Authors:  Xosé R Bustelo; Vincent Sauzeau; Inmaculada M Berenjeno
Journal:  Bioessays       Date:  2007-04       Impact factor: 4.345

4.  Spatial mapping of the neurite and soma proteomes reveals a functional Cdc42/Rac regulatory network.

Authors:  Olivier C Pertz; Yingchun Wang; Feng Yang; Wei Wang; Laurie J Gay; Marina A Gristenko; Therese R Clauss; David J Anderson; Tao Liu; Kenneth J Auberry; David G Camp; Richard D Smith; Richard L Klemke
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-01       Impact factor: 11.205

5.  ARHGAP4 is a novel RhoGAP that mediates inhibition of cell motility and axon outgrowth.

Authors:  D L Vogt; C D Gray; W S Young; S A Orellana; A T Malouf
Journal:  Mol Cell Neurosci       Date:  2007-07-24       Impact factor: 4.314

Review 6.  Establishment of epithelial polarity--GEF who's minding the GAP?

Authors:  Siu P Ngok; Wan-Hsin Lin; Panos Z Anastasiadis
Journal:  J Cell Sci       Date:  2014-07-02       Impact factor: 5.285

7.  Creatine kinase B is necessary to limit myoblast fusion during myogenesis.

Authors:  Adriana Simionescu-Bankston; Christophe Pichavant; James P Canner; Luciano H Apponi; Yanru Wang; Craig Steeds; John T Olthoff; Joseph J Belanto; James M Ervasti; Grace K Pavlath
Journal:  Am J Physiol Cell Physiol       Date:  2015-03-25       Impact factor: 4.249

8.  ARHGAP21 protein, a new partner of α-tubulin involved in cell-cell adhesion formation and essential for epithelial-mesenchymal transition.

Authors:  Karin S A Barcellos; Carolina L Bigarella; Mark V Wagner; Karla P Vieira; Mariana Lazarini; Peter R Langford; João A Machado-Neto; Steven G Call; Davis M Staley; Jarom Y Chung; Marc D Hansen; Sara T O Saad
Journal:  J Biol Chem       Date:  2012-12-12       Impact factor: 5.157

Review 9.  The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.

Authors:  Maria Antonietta De Matteis; Leopoldo Staiano; Francesco Emma; Olivier Devuyst
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

10.  A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway.

Authors:  Kai S Erdmann; Yuxin Mao; Heather J McCrea; Roberto Zoncu; Sangyoon Lee; Summer Paradise; Jan Modregger; Daniel Biemesderfer; Derek Toomre; Pietro De Camilli
Journal:  Dev Cell       Date:  2007-09       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.